Roundup Weed Killer Lawsuit (Monsanto/Bayer)
Roundup herbicide containing glyphosate has been linked to non-Hodgkin lymphoma. Bayer has paid billions in settlements.
Last updated: 2026-02-28
What Is This Lawsuit About?
The Roundup lawsuit is one of the most significant product liability mass tort cases in U.S. history. Tens of thousands of plaintiffs allege that Monsanto (now owned by Bayer AG) knew for decades that its flagship herbicide product, Roundup, could cause cancer — specifically non-Hodgkin lymphoma (NHL) — and failed to warn users of this risk.
Roundup's active ingredient, glyphosate, is the most widely used herbicide in the world. It has been sprayed on farms, lawns, gardens, parks, and roadsides for over 40 years. In March 2015, the World Health Organization's International Agency for Research on Cancer (IARC) classified glyphosate as "probably carcinogenic to humans" (Group 2A), based on evidence from epidemiological studies, animal studies, and mechanistic data.
Following this classification, lawsuits began pouring in. The first trial, Johnson v. Monsanto (2018), resulted in a landmark $289 million verdict for school groundskeeper Dewayne Johnson, who had terminal non-Hodgkin lymphoma. Two subsequent trials in 2019 produced verdicts of $80 million (Hardeman) and over $2 billion (Pilliod, later reduced). These verdicts demonstrated that juries found Monsanto liable for failing to warn about cancer risks.
In June 2020, Bayer announced a comprehensive $10.9 billion settlement to resolve approximately 75% of the estimated 125,000 pending and unfiled claims. As of 2025, Bayer has reported over 170,000 total claims related to Roundup, and litigation continues for cases not covered by the initial settlement.
Landmark Roundup Trial Verdicts
Who Qualifies?
The Roundup lawsuit is open to individuals who have a history of regular exposure to Roundup or other glyphosate-based herbicides and were subsequently diagnosed with non-Hodgkin lymphoma or certain other blood cancers. Both professional users (farmers, landscapers, groundskeepers) and regular residential users may qualify.
There is no single "minimum exposure threshold" established in court, but successful plaintiffs have generally demonstrated a pattern of repeated use over months or years. The stronger the documented exposure history and the clearer the link between exposure and diagnosis, the stronger the claim.
Do You Qualify for the Roundup Lawsuit?
You may be eligible to file a Roundup claim if the following apply to you:
- Regular use of Roundup or other glyphosate-based herbicides (professional or residential)
- Exposure lasted for an extended period (months to years of regular use)
- Diagnosed with non-Hodgkin lymphoma (NHL) after exposure to Roundup
- Other qualifying cancers may include: chronic lymphocytic leukemia, B-cell lymphoma, T-cell lymphoma
- Agricultural workers, landscapers, groundskeepers, and farmers with regular exposure
- Residential users who regularly applied Roundup to lawns, gardens, or driveways
- Family members of deceased Roundup users may file wrongful death claims
Roundup Products Containing Glyphosate
Monsanto (now Bayer) manufactured and sold a wide range of glyphosate-based herbicide products under the Roundup brand name and other labels. If you used any of the following products regularly, you may have been exposed to the active ingredient at the center of this litigation:
Products Named in This Lawsuit
Roundup Ready-To-Use Weed & Grass Killer
by Monsanto/Bayer
Consumer spray bottle product for residential use
Roundup Concentrate Plus
by Monsanto/Bayer
Concentrated formula mixed with water for larger applications
Roundup Pro Concentrate
by Monsanto/Bayer
Professional-grade formula for commercial and agricultural use
Roundup ProMax
by Monsanto/Bayer
High-concentration professional product for large-scale weed control
Roundup QuikPro
by Monsanto/Bayer
Fast-acting dry formula for professional applicators
Roundup Custom
by Monsanto/Bayer
Aquatic-approved glyphosate herbicide for specialized applications
Roundup PowerMax
by Monsanto/Bayer
Agricultural-grade glyphosate for crop production
Ranger Pro
by Monsanto/Bayer
Generic glyphosate brand marketed alongside Roundup products
In addition to Roundup-branded products, glyphosate is the active ingredient in numerous other herbicides sold by different manufacturers. If you used any glyphosate-containing product and developed non-Hodgkin lymphoma, you should consult with an attorney about your potential claim.
Think You May Qualify?
Get a free, no-obligation case review from an experienced attorney. You pay nothing unless you win.
Lawsuit Timeline
The Roundup litigation has unfolded over nearly a decade, from the initial IARC cancer classification through landmark jury verdicts and the largest product liability settlement in U.S. history. Understanding this timeline provides critical context for where the litigation stands today and what new claimants can expect.
Lawsuit Timeline
Roundup Introduced
Monsanto introduces Roundup herbicide containing glyphosate to the commercial market. It quickly becomes the world's most widely used weed killer.
Roundup Ready Crops Launched
Monsanto introduces genetically modified "Roundup Ready" crops, dramatically increasing glyphosate usage in agriculture across the United States and globally.
IARC Classification
The World Health Organization's International Agency for Research on Cancer (IARC) classifies glyphosate as "probably carcinogenic to humans" (Group 2A).
First Lawsuits Filed
Plaintiffs begin filing lawsuits against Monsanto alleging that Roundup caused their non-Hodgkin lymphoma and that Monsanto concealed the cancer risk.
Bayer Acquires Monsanto
Bayer completes its $63 billion acquisition of Monsanto, inheriting the growing Roundup litigation liability.
Johnson v. Monsanto Verdict
A San Francisco jury awards school groundskeeper Dewayne Johnson $289 million (later reduced to $78.5 million on appeal), the first Roundup trial verdict.
Hardeman Verdict
A federal jury in the Hardeman v. Monsanto bellwether trial awards Edwin Hardeman $80 million in damages.
Pilliod Verdict
A California jury awards Alva and Alberta Pilliod over $2 billion (later reduced to $86.7 million), the largest Roundup verdict to date.
Bayer $10.9B Settlement
Bayer announces a $10.9 billion settlement to resolve approximately 75% of the roughly 125,000 filed and unfiled Roundup claims.
Ongoing Litigation
New cases continue to be filed. Bayer faces additional trials and continues to resolve claims. The company reported over 170,000 total claims as of 2024.
Settlement Amounts & Key Verdicts
The Roundup litigation has produced some of the most significant jury verdicts and settlement figures in mass tort history. In June 2020, Bayer agreed to pay $10.9 billion to resolve the majority of pending Roundup claims — one of the largest product liability settlements ever.
Individual settlement amounts within this fund have varied based on factors such as the severity and type of non-Hodgkin lymphoma, the age of the plaintiff, the duration and intensity of Roundup exposure, and the strength of the causation evidence. Reports suggest that average individual settlements have ranged from approximately $5,000 to over $250,000, with higher-tier claims for severe or fatal cases receiving significantly more.
It is important to note that jury verdicts (like the $289M Johnson verdict or $2B Pilliod verdict) represent the highest possible outcomes and are often substantially reduced on appeal. However, they establish important legal precedents about Monsanto's liability and influence settlement negotiations for all claimants.
Estimated Settlement Ranges
These ranges are estimates based on publicly available settlement data and comparable cases. Individual results vary significantly.
Bayer's Roundup Financial Commitment
How to File a Roundup Claim
If you believe you qualify for the Roundup lawsuit, the process of filing a claim involves several important steps. Working with an experienced attorney is strongly recommended, as the litigation involves complex scientific evidence and specific legal requirements. Learn more about the general process in our guide on how to join a mass tort lawsuit.
How the Process Works
Evaluate Your Exposure History
Document your history of Roundup or glyphosate-based herbicide use, including the duration, frequency, and approximate dates of exposure.
Confirm Your Diagnosis
Obtain medical records confirming a diagnosis of non-Hodgkin lymphoma or another qualifying condition that developed after exposure to Roundup.
Consult a Mass Tort Attorney
Contact an experienced Roundup lawsuit attorney for a free case evaluation. Most work on contingency — you pay nothing unless you win.
File Your Claim
Your attorney will prepare and file your lawsuit, either as an individual case or as part of the multidistrict litigation (MDL 2741).
Discovery & Case Development
Your legal team will gather evidence, medical records, and expert testimony to build your case and establish the link between Roundup and your condition.
Settlement or Trial
Most Roundup cases have resolved through settlement. Your attorney will negotiate for fair compensation or take your case to trial if necessary.
Most Roundup attorneys work on a contingency fee basis, meaning you owe no attorney fees unless your case results in a settlement or verdict. This ensures that pursuing a claim costs you nothing out of pocket.
Named Defendants
The primary defendants in the Roundup litigation are:
- • Monsanto Company — The original manufacturer of Roundup and developer of glyphosate-based herbicide products. Monsanto developed and sold Roundup since 1974 and was the primary target of litigation alleging concealment of cancer risks. Monsanto is now a wholly owned subsidiary of Bayer.
- • Bayer AG — The German pharmaceutical and chemical company that acquired Monsanto in June 2018 for $63 billion. As the parent company, Bayer assumed all of Monsanto's legal liabilities, including the Roundup litigation. Bayer has been the defendant in all trials conducted after the acquisition and is responsible for the $10.9 billion settlement fund.
Internal Monsanto documents obtained during litigation (often called the "Monsanto Papers") revealed that the company had engaged in ghostwriting scientific studies, attacking independent researchers who raised cancer concerns, and cultivating relationships with EPA officials to influence regulatory review — evidence that juries found particularly damning in the initial trial verdicts.
Scientific & Medical Evidence
The scientific case against glyphosate and Roundup is built on decades of research from independent scientists, government agencies, and international health organizations. Key evidence includes:
IARC Classification (2015)
The WHO's International Agency for Research on Cancer evaluated the totality of evidence and classified glyphosate as "probably carcinogenic to humans" (Group 2A). This assessment was based on "limited" evidence of cancer in humans (from epidemiological studies of NHL) and "sufficient" evidence of cancer in experimental animals.
Epidemiological Studies
Multiple epidemiological studies, including the Agricultural Health Study (a large prospective cohort study involving over 50,000 pesticide applicators), have examined the relationship between glyphosate exposure and cancer. A 2019 meta-analysis published in Mutation Research found a 41% increased risk of non-Hodgkin lymphoma with high cumulative glyphosate exposure.
The "Monsanto Papers"
Internal corporate documents obtained during discovery revealed that Monsanto had commissioned ghostwritten scientific papers to downplay cancer risks, attacked IARC scientists after the 2015 classification, and worked to influence EPA review processes. These documents were critical in establishing Monsanto's knowledge of potential risks and intent to conceal them.
Regulatory Disagreements
While the IARC classified glyphosate as probably carcinogenic, the U.S. EPA concluded in a 2020 interim decision that glyphosate is "not likely to be carcinogenic to humans." This disagreement between agencies has been a central point of contention in the litigation. Plaintiffs' experts have challenged the EPA's methodology and noted that its review relied heavily on industry-funded studies.
For broader context on how chemical exposure lawsuits are evolving, see the related PFAS "Forever Chemicals" lawsuit, the Paraquat Parkinson's disease lawsuit, and the Hair Relaxer cancer lawsuit.
Frequently Asked Questions
Frequently Asked Questions
Who qualifies for the Roundup lawsuit?
What types of cancer are linked to Roundup?
How much compensation can I receive from the Roundup lawsuit?
Is there a deadline to file a Roundup lawsuit?
Can I still file a Roundup lawsuit even though Bayer already settled?
Do I need to prove I used Roundup specifically, or do other glyphosate products count?
How long does the Roundup lawsuit process take?
Does Roundup still contain glyphosate?
Legal Disclaimer
This is for informational purposes only and does not constitute legal advice. It does not create an attorney-client relationship. The information presented may not reflect the most current legal developments. Consult a qualified attorney in your jurisdiction for advice about your specific situation.
Free Case Review — See If You Qualify
No obligation. No upfront costs. Attorneys work on contingency — you pay nothing unless you win.
Related Lawsuits
Camp Lejeune Lawsuit
Water contamination at Marine Corps Base Camp Lejeune, NC exposed service members and families to toxic chemicals from 1953-1987.
Suboxone Lawsuit
Suboxone sublingual film for opioid addiction has caused severe dental problems including tooth decay, cavities, and tooth loss. FDA required warning update in 2022.
Dupixent Lawsuit
Dupixent (dupilumab) for eczema and asthma linked to cutaneous T-cell lymphoma at 30x the rate of other medications. FDA flagged the risk in March 2025.